Symbol Lookup

Wednesday April 16, 2014 3:32 AM ET. Data delayed 15 minutes.
-0.17 (-0.73%)
Open/Prev Close
Day Range
52-Week Range
Vol/Avg Daily Vol
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
No documents available

Company Information

Trinity Biotech plc (Trinity Biotech)develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The Company is a provider of raw materials to the life sciences industry and research institutes globally through the Company subsidiary, Fitzgerald Industries. It markets its portfolio of over 275 products to customers in 75 countries around the world. It markets its products in the United States through a direct sales force and in the rest of the world through a combination of direct selling and a network of distributors. On July 26, 2013, it acquired Immco Diagnostics Inc.


HeadquartersIDA Business Park, Co Wicklow
BRAY, Ireland


Executive Chairman of the BoardRonan O'Caoimh
Chief Financial Officer, SecretaryKevin Tansley
Chief Operating Officer, Executive DirectorRory Nealon
Chief Scientific Officer, Executive DirectorJames Walsh
Non-Executive DirectorClinton Severson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$533.1MBeta0.69
Revenue (TTM)$86.6MEPS$0.41
Shares Out.23.1MBook Value$7.85
Dividend Yield0.87%P/E55.9x
Annual Dividend Rate$0.20Price/Sales (TTM)6.2
Ex-Div Date6/6/13P/Cash Flow (TTM)--
Pay Date7/1/13Operating Margin19.90%

*GAAP = prior to non-GAAP analyst adjusted earnings.


Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample